Loading...
| A06107 | Pages: 154 | Mar 2020 | 3378 Views | | |
| Author(s) : Sanjivan Gill | Tables: 85 | Charts: 22 |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Uv Infection Control Devices Market
Request Now !The global UV infection control devices market size was valued at $317.42 million in 2018, and is projected to reach $524.84 million by 2026, registering a CAGR of 6.5% from 2019 to 2026.
The UV infection control device is one of the disinfectant systems that use ultraviolet rays to kill microorganism present in the various healthcare setting such as hospitals, clinics, ambulatory surgical centers, research center, emergency departments, and others. As health care-associated infections (HAIs) is on the rise every year, which are caused by microorganisms such as fungi, bacteria, viruses, and parasites that can seriously affect the patients. The UV infection control device works based on UV light that reflects off walls and other surfaces and is absorbed by bacteria, whose light-sensitive porphyrin molecules become excited and, as a result, experience oxidative damage and cell death.
Get more information on this report : Request Sample Pages
The key factors that drive the growth of the UV infection control devices market include increase in government focus on infection control programs. For instance, the American Hospital Association published "Infection Control in the Hospital," the first and only standards available for many years. In 2015 more than 50% of US hospitals had a version of an infection control program. In 1972, the Hospital Infections Branch at the CDC was formed, and the Association for Practitioners in Infection Control was organized. Furthermore, rise in prevalence of hospital acquired infections (HAI). In addition, rising adoption of technologically advanced UV equipment further supplement the growth of the market. However, high cost of UV infection control devices and stringent government regulations hinder the growth of the market globally. On the contrary, high growth prospects in emerging markets can provide newer opportunities for the UV infection control devices market growth.
UV Infection Control Devices Market Segmentation
The global UV infection control devices market is segmented on the basis of type, end user, and region. By type, the market is classified into mobile, stationary, and other types. By end user, the market is segmented into hospitals, clinics, and others. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Russia, and rest of Europe), Asia-Pacific (China, Japan, India, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
Segment Review
By type, the market is classified into mobile, stationary, and other types. The mobile segment dominated in 2018 and is expected to continue to maintain the lead over the forecast period. This is attributed to its mobility; as the device is light and can be moved to different settings. In addition, the cost of mobile UV infection control devices is less expensive than the stationary IV infection control devices. Furthermore, various benefits offered by these devices also contribute to the growth of the market. For instance, these devices eradicate the infectious diseases by killing them whereas other disinfecting agents act by inhibiting the growth of infectious diseases. Furthermore, these mobile units are specifically designed for the ease of use and elimination of human error. For instance, mobile UV infection devices are available with casters or with a handcarts for maximum mobility. Therefore, the factors aforementioned contribute to the growth of the market.
Get more information on this report : Request Sample Pages
By end user, the market is segmented into hospitals, clinics, and others. The hospital segment occupied the largest share of the UV infection control devices market in 2018 owing to factors such as rise in number of UV infection control devices that are used in the medical devices due to surge in cases of hospital acquired infections. In addition, the surge in number of hospitals worldwide is further supporting the market growth. Hospital segment is also the fastest growing end user segment in the market.
Get more information on this report : Request Sample Pages
By region, North America accounted for the major UV infection control devices market share in 2018 and is expected to continue this trend, owing to presence of well-established healthcare infrastructure, higher buying power, and high adoption of advanced medical equipment. In addition, rise in cases of hospital acquired infection (HAIs) is another major factor that boosts the growth of the market. On the other side, Asia-Pacific is estimated to register the fastest growth during the forecast period, which is attributed to highly populated countries, with China being the first and India the second most populated countries. Therefore, the region has the potential to offer a huge patient base, which is expected to boost the growth of the Asia-Pacific UV infection control devices market. Furthermore, the improvements in health standards, surge in disposable incomes, and advancements in technology for the development of new UV infection control devices also contribute to the growth of the market in the region.
The global UV infection control devices market is highly competitive and the prominent players in the market have adopted various strategies to garner maximum market share. These include collaboration, product launch, partnership, and acquisition. Some of the key players operating in the UV infection control devices market are CVS Health Corporation, DocMorris, Express Scripts Holding Company, Giant Eagle Inc., Optum Rx Inc., Rowlands Pharmacy, The Kroger Co., Walgreen Co., Walmart Stores Inc., and Apollo Pharmacy.
Get more information on this report : Request Sample Pages
Key Market Segments
Key Market Players
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top player positioning, 2018
3.3. Porter's five force analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in government focus on infection control programs
3.4.1.2. Increase in the prevalence of hospital acquired infections (HAI)
3.4.1.3. Rising adoption of technologically advanced UV equipment
3.4.2. Restraints
3.4.2.1. High cost of UV infection control devices
3.4.2.2. Stringent government regulations
3.4.3. Opportunity
3.4.3.1. High growth prospects in emerging markets
CHAPTER 4: UV INFECTION CONTROL DEVICES MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Mobile Type
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Station Type
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Other Types
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
CHAPTER 5: GLOBAL UV INFECTION CONTROL DEVICES MARKET, BY END USER
5.1. Overview
5.1.1. Market size and forecast
5.2. Hospitals
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Clinics
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
5.4. Others
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country
CHAPTER 6: UV INFECTION CONTROL DEVICES MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends and opportunities
6.2.2. North America UV infection control devices market, by country
6.2.2.1. U.S. UV infection control devices market, by type
6.2.2.2. U.S. UV infection control devices market, by end user
6.2.2.3. Canada UV infection control devices market, by type
6.2.2.4. Canada UV infection control devices market, by end user
6.2.2.5. Mexico UV infection control devices market, by type
6.2.2.6. Mexico UV infection control devices market, by end user
6.2.3. North America market size and forecast, by type
6.2.4. North America market size and forecast, by end user
6.3. Europe
6.3.1. Key market trends and opportunities
6.3.2. Europe UV infection control devices market, by country
6.3.2.1. Germany UV infection control devices market, by type
6.3.2.2. Germany UV infection control devices market, by end user
6.3.2.3. France UV infection control devices market, by type
6.3.2.4. France UV infection control devices market, by end user
6.3.2.5. UK UV infection control devices market, by type
6.3.2.6. UK UV infection control devices market, by end user
6.3.2.7. Italy UV infection control devices market, by type
6.3.2.8. Italy UV infection control devices market, by end user
6.3.2.9. Russia UV infection control devices market, by type
6.3.2.10. Russia UV infection control devices market, by end user
6.3.2.11. Rest of Europe UV infection control devices market, by type
6.3.2.12. Rest of Europe UV infection control devices market, by end user
6.3.3. Europe market size and forecast, by type
6.3.4. Europe market size and forecast, by end user
6.4. Asia-Pacific
6.4.1. Key market trends and opportunities
6.4.2. Asia-Pacific UV infection control devices market, by country
6.4.2.1. Japan UV infection control devices market, by type
6.4.2.2. Japan UV infection control devices market, by end user
6.4.2.3. China UV infection control devices market, by type
6.4.2.4. China UV infection control devices market, by end user
6.4.2.5. India UV infection control devices market, by type
6.4.2.6. India UV infection control devices market, by end user
6.4.2.7. Rest of Asia-Pacific UV infection control devices market, by type
6.4.2.8. Rest of Asia-Pacific UV infection control devices market, by end user
6.4.3. Asia-Pacific market size and forecast, by type
6.4.4. Asia-Pacific market size and forecast, by end user
6.5. LAMEA
6.5.1. Key market trends and opportunities
6.5.2. LAMEA UV infection control devices market, by country
6.5.2.1. Brazil UV infection control devices market, by type
6.5.2.2. Brazil UV infection control devices market, by end user
6.5.2.3. Saudi Arabia UV infection control devices market, by type
6.5.2.4. Saudi Arabia UV infection control devices market, by end user
6.5.2.5. South Africa UV infection control devices market, by type
6.5.2.6. South Africa UV infection control devices market, by end user
6.5.2.7. Rest of LAMEA UV infection control devices market, by type
6.5.2.8. Rest of LAMEA UV infection control devices market, by end user
6.5.3. LAMEA market size and forecast, by type
6.5.4. LAMEA market size and forecast, by end user
CHAPTER 7: COMPANY PROFILES
7.1. American Air & Water, Inc.
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.2. American Ultraviolet
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.3. Lumalier Corp
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.4. Nikkiso Co., Ltd.
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance
7.5. PDI, Inc.
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.1. Key strategic moves and developments
7.6. Seal Shield, LLC
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.7. STERIS plc.
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.8. THE CLOROX COMPANY
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.9. UVC Cleaning Systems
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.10. XENEX
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
7.10.5. Key strategic moves and developments
LIST OF TABLES
TABLE 01. UV INFECTION CONTROL DEVICES MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 02. UV INFECTION CONTROL DEVICES MARKET FOR MOBILE TYPE, BY REGION 2018–2026 ($MILLION)
TABLE 03. UV INFECTION CONTROL DEVICES MARKET FOR STATION TYPE, BY REGION 2018–2026 ($MILLION)
TABLE 04. UV INFECTION CONTROL DEVICES MARKET FOR OTHER TYPES, BY REGION 2018–2026 ($MILLION)
TABLE 05. UV INFECTION CONTROL DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 06. UV INFECTION CONTROL DEVICES MARKET FOR HOSPITALS, BY REGION 2018–2026 ($MILLION)
TABLE 07. UV INFECTION CONTROL DEVICES MARKET FOR CLINICS, BY REGION 2018–2026 ($MILLION)
TABLE 08. UV INFECTION CONTROL DEVICES MARKET FOR OTHER END USER, BY REGION 2018–2026 ($MILLION)
TABLE 09. UV INFECTION CONTROL DEVICES MARKET REVENUE, BY REGION, 2018–2026 ($MILLION)
TABLE 10. NORTH AMERICA UV INFECTION CONTROL DEVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 11. U.S. UV INFECTION CONTROL DEVICES MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 12. U.S. UV INFECTION CONTROL DEVICES, BY END USER 2018–2026 ($MILLION)
TABLE 13. CANADA UV INFECTION CONTROL DEVICES MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 14. CANADA UV INFECTION CONTROL DEVICES, BY END USER 2018–2026 ($MILLION)
TABLE 15. MEXICO UV INFECTION CONTROL DEVICES MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 16. MEXICO UV INFECTION CONTROL DEVICES MARKET, BY END USER 2018–2026 ($MILLION)
TABLE 17. NORTH AMERICA UV INFECTION CONTROL DEVICES REVENUE, BY TYPE, 2019–2026($MILLION)
TABLE 18. NORTH AMERICA UV INFECTION CONTROL DEVICES MARKET REVENUE, BY END USER, 2019–2026($MILLION)
TABLE 19. EUROPE UV INFECTION CONTROL DEVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 20. GERMANY UV INFECTION CONTROL DEVICES MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 21. GERMANY UV INFECTION CONTROL DEVICES MARKET, BY END USER 2018–2026 ($MILLION)
TABLE 22. FRANCE UV INFECTION CONTROL DEVICES MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 23. FRANCE UV INFECTION CONTROL DEVICES MARKET, BY END USER 2018–2026 ($MILLION)
TABLE 24. UK UV INFECTION CONTROL DEVICES MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 25. UK UV INFECTION CONTROL DEVICES MARKET, BY END USER 2018–2026 ($MILLION)
TABLE 26. ITALY UV INFECTION CONTROL DEVICES MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 27. ITALY. UV INFECTION CONTROL DEVICES MARKET, BY END USER 2018–2026 ($MILLION)
TABLE 28. RUSSIA UV INFECTION CONTROL DEVICES MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 29. RUSSIA UV INFECTION CONTROL DEVICES MARKET, BY END USER 2018–2026 ($MILLION)
TABLE 30. REST OF EUROPE UV INFECTION CONTROL DEVICES MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 31. REST OF EUROPE UV INFECTION CONTROL DEVICES MARKET, BY END USER 2018–2026 ($MILLION)
TABLE 32. EUROPE UV INFECTION CONTROL DEVICES MARKET REVENUE, BY TYPE, 2019–2026($MILLION)
TABLE 33. EUROPE UV INFECTION CONTROL DEVICES MARKET REVENUE, BY END USER, 2019–2026($MILLION)
TABLE 34. ASIA-PACIFIC UV INFECTION CONTROL DEVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 35. JAPAN UV INFECTION CONTROL DEVICES MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 36. JAPAN UV INFECTION CONTROL DEVICES MARKET, BY END USER 2018–2026 ($MILLION)
TABLE 37. CHINA UV INFECTION CONTROL DEVICES MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 38. CHINA UV INFECTION CONTROL DEVICES MARKET, BY END USER 2018–2026 ($MILLION)
TABLE 39. INDIA UV INFECTION CONTROL DEVICES MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 40. INDIA UV INFECTION CONTROL DEVICES MARKET, BY END USER 2018–2026 ($MILLION)
TABLE 41. REST OF ASIA-PACIFIC UV INFECTION CONTROL DEVICES MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 42. REST OF ASIA-PACIFIC UV INFECTION CONTROL DEVICES MARKET, BY END USER 2018–2026 ($MILLION)
TABLE 43. ASIA-PACIFIC UV INFECTION CONTROL DEVICES MARKET REVENUE, BY TYPE, 2019–2026($MILLION)
TABLE 44. ASIA-PACIFIC UV INFECTION CONTROL DEVICES MARKET REVENUE, BY END USER, 2019–2026($MILLION)
TABLE 45. LAMEA UV INFECTION CONTROL DEVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 46. BRAZIL UV INFECTION CONTROL DEVICES MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 47. BRAZIL UV INFECTION CONTROL DEVICES MARKET, BY END USER 2018–2026 ($MILLION)
TABLE 48. SAUDI ARABIA UV INFECTION CONTROL DEVICES MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 49. SAUDI ARABIA UV INFECTION CONTROL DEVICES MARKET, BY END USER 2018–2026 ($MILLION)
TABLE 50. SOUTH AFRICA UV INFECTION CONTROL DEVICES MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 51. SOUTH AFRICA UV INFECTION CONTROL DEVICES MARKET, BY END USER 2018–2026 ($MILLION)
TABLE 52. REST OF LAMEA UV INFECTION CONTROL DEVICES MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 53. REST OF LAMEA UV INFECTION CONTROL DEVICES MARKET, BY END USER 2018–2026 ($MILLION)
TABLE 54. LAMEA UV INFECTION CONTROL DEVICES MARKET REVENUE, BY TYPE, 2019–2026($MILLION)
TABLE 55. LAMEA UV INFECTION CONTROL DEVICES MARKET REVENUE, BY END USER, 2019–2026($MILLION)
TABLE 56. AMERICAN AIR & WATER, INC.: COMPANY SNAPSHOT
TABLE 57. AMERICAN AIR & WATER, INC.: OPERATING SEGMENTS
TABLE 58. AMERICAN AIR & WATER, INC.: PRODUCT PORTFOLIO
TABLE 59. AMERICAN ULTRAVIOLET: COMPANY SNAPSHOT
TABLE 60. AMERICAN ULTRAVIOLET: OPERATING SEGMENTS
TABLE 61. AMERICAN ULTRAVIOLET: PRODUCT PORTFOLIO:
TABLE 62. LUMALIER: COMPANY SNAPSHOT
TABLE 63. LUMALIER: OPERATING SEGMENTS
TABLE 64. LUMALIER: PRODUCT PORTFOLIO
TABLE 65. NIKKISO: COMPANY SNAPSHOT
TABLE 66. NIKKISO: OPERATING SEGMENTS
TABLE 67. NIKKISO: PRODUCT PORTFOLIO
TABLE 68. PDI: COMPANY SNAPSHOT
TABLE 69. PDI: OPERATING SEGMENTS
TABLE 70. PDI: PRODUCT PORTFOLIO
TABLE 71. SEAL SHIELD: COMPANY SNAPSHOT
TABLE 72. SEAL SHIELD, LLC: PRODUCT SEGMENTS
TABLE 73. SEAL SHIELD: PRODUCT PORTFOLIO
TABLE 74. STERIS: COMPANY SNAPSHOT
TABLE 75. STERIS: OPERATING SEGMENTS
TABLE 76. STERIS: PRODUCT PORTFOLIO
TABLE 77. THE CLOROX COMPANY: COMPANY SNAPSHOT
TABLE 78. THE CLOROX COMPANY: OPERATING SEGMENTS
TABLE 79. THE CLOROX COMPANY: PRODUCT PORTFOLIO
TABLE 80. UVC CLEANING SYSTEMS: COMPANY SNAPSHOT
TABLE 81. UVC CLEANING SYSTEMS: OPERATING SEGMENTS
TABLE 82. UVC CLEANING SYSTEMS: PRODUCT PORTFOLIO
TABLE 83. XENEX.: COMPANY SNAPSHOT
TABLE 84. XENEX.: OPERATING SEGMENTS
TABLE 85. XENEX: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01. TOP INVESTMENT POCKETS
FIGURE 02. TOP PLAYER POSITIONING, 2018
FIGURE 03. LOW BARGAINING POWER OF SUPPLIERS
FIGURE 04. MODERATE BARGAINING POWER OF BUYERS
FIGURE 05. MODERATE THREAT OF NEW ENTRANTS
FIGURE 06. HIGH THREAT OF SUBSTITUTION
FIGURE 07. MODERATE INTENSITY OF COMPETITIVE RIVALRY
FIGURE 08. COMPARATIVE SHARE ANALYSIS OF UV INFECTION CONTROL DEVICES MARKET FOR MOBILE TYPE, BY COUNTRY, 2018 & 2026 (%)
FIGURE 09. COMPARATIVE SHARE ANALYSIS OF UV INFECTION CONTROL DEVICES MARKET FOR STATION TYPE, BY COUNTRY, 2018 & 2026 (%)
FIGURE 10. COMPARATIVE SHARE ANALYSIS OF UV INFECTION CONTROL DEVICES MARKET FOR OTHERS THERAPY, BY COUNTRY, 2018 & 2026 (%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF UV INFECTION CONTROL DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF UV INFECTION CONTROL DEVICES MARKET FOR CLINICS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF UV INFECTION CONTROL DEVICES MARKET FOR OTHER END USER, BY COUNTRY, 2018 & 2026 (%)
FIGURE 14. NIKKISO: NET SALES, 2017–2018 ($MILLION)
FIGURE 15. NIKKISO REVENUE SHARE BY SEGMENTS, 2018 (%)
FIGURE 16. NIKKISO: REVENUE SHARE BY REGIONS, 2018 (%)
FIGURE 17. STERIS: NET SALES, 2017–2019 ($MILLION)
FIGURE 18. STERIS: REVENUE SHARE BY SEGMENT, 2019(%)
FIGURE 19. STERIS: REVENUE SHARE BY REGION, 2019(%)
FIGURE 20. NET SALES, 2017–2019 ($MILLION)
FIGURE 21. THE CLOROX COMPANY: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 22. THE CLOROX COMPANY: REVENUE SHARE BY REGION, 2019 (%)
UV infection control devices are used to prevent infection in the healthcare settings including hospitals, emergency departments, clinics, ambulatory surgical center, and others. The adoption of UV infection control devices is expected to increase due to rise in the medical procedures, high demand of infection control system, and surge in demand of cost-effective medical devices.
Upsurge in cases of chronic diseases and increase in the surgical procedure helps to increase the demand of infection control devices in the operating rooms. Moreover, increase in government focus on infection control programs and increase in the prevalence of hospital acquired infections (HAI) fuel the growth of the market. In addition, rise in adoption of technologically advanced UV equipment further supplement the growth of the market.
A. The total market value of UV infection control devices market is $317.42 million in 2018.
A. The forcast period for UV infection control devices market is 2019 to 2026
A. The market value of UV infection control devices market in 2019 is $337.29 million.
A. The base year is 2018 in UV infection control devices market
A. Top companies such as, Nikkiso Co., Ltd., STERIS plc., The Clorox Company, American Ultraviolet, and UVC Cleaning Systems held a high market position in 2018. These key players held a high market postion owing to the strong geographical foothold in different regions.
A. Mobile type segment is the most influencing segment owing to surge in the prevalence of hospital acquired infections across the globe which lead to surge in the need of these devices.
A. The major factor that fuels the growth of the global UV infection control devices market includes increase in government focus on infection control programs across the world which led to surge in awareness towards the use of UV infection control devices.
A. Asia-Pacific has the highest growth rate in the market which is growing due to the contribution of the following emerging countries such as India with a CAGR of 9.1%. This is due to improvements in health standards, surge in disposable incomes, and advancements in technology for the development of new UV infection control devices.
A. UV infection control device is one of the disinfectant systems that use ultraviolet rays to kill microorganism present in the various healthcare setting such as hospitals, clinics, ambulatory surgical centers, research center, emergency departments, and others.
A. UV infection control devices are used to kill infection causing organisms such as bacteria, virus and others
Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Buy Now *Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
